Developer docs
API playgroundTry for free, no card

Search company profiles

Lymphoma Coalition

Full company profile

uuid000y9av

Namestring
Lymphoma Coalition
Legal namestring
Lymphoma Coalition
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Lymphoma Coalition is a Canadian-incorporated non-profit and global patient advocacy network focused on lymphoma and chronic lymphocytic leukemia (CLL). Founded in 2002 by four lymphoma organizations and incorporated as a not-for-profit in 2010, it functions as a central hub connecting over 90 patient member organizations across 55 countries. Its core "products" are information assets and programs rather than commercial software: a biennial Global Patient Survey on Lymphomas & CLL, country-level Global Report Cards, a searchable Resource Library of 4,000+ articles, a Clinical Trial Search tool, a Treatment Database, a Lymphoma Subtypes Information Library covering B-cell and T-cell lymphomas, and dedicated hubs on CAR-T therapy, Genetic Markers, Biosimilars, and Psychosocial Effects. The organization also publishes policy resources including Health Technology Assessment (HTA) materials, the Lymphoma Patient Charter, the Global Health Expenditure Report 2024, and runs the annual World Lymphoma Awareness Day campaign plus the Karen Van Rassel Leadership Award.

The business model is that of a non-profit coalition rather than a commercial enterprise. LC is funded through a mix of sources typical of patient advocacy organizations (pharmaceutical unrestricted educational grants, member dues, donations, and partnerships), and revenue figures are not publicly disclosed. It has a small paid staff (1–10 employees) and is led by CEO Lorna Warwick until her December 2026 retirement; other named leaders include Natacha Bolaños (Head, Membership & Alliance) and Kathryn Perry (Head, Communications & Information). Its customer base is two-sided: member patient organizations (the primary institutional customers and channel partners) and individual patients affected by lymphoma, with secondary audiences of healthcare professionals, researchers, and policy advocates. Geographic reach is explicitly global, with active operations in Europe, Asia Pacific, North America, Latin America, and Africa, and a regional substructure for Lymphoma Coalition Europe.

Recent strategic emphasis has been on deepening clinical and policy relevance: LC supported the formation of Women in Lymphoma (WiL) in 2019, facilitated the 2021 merger of France Lymphome Espoir and SILLC into ELLyE, and announced a strategic partnership with WiL in June 2026 to combine its patient advocacy network with WiL's clinician/researcher community. As an independent non-profit with no parent company, no private equity ownership, and no public listing, governance rests with a Board of Directors, and the organization is currently conducting a global CEO search.

Short descriptiontext

Lymphoma Coalition is a Canadian non-profit global network of over 90 patient member organizations across 55 countries, providing lymphoma and CLL patient education, advocacy, research, and policy resources since 2002.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEtobicoke, Canada
HQ citystring
Etobicoke
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy network, lymphoma research, cancer support services, healthcare education resources, nonprofit patient organization
Industry2 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAO
Global Health Advocacy, Policy & Rights Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
NAICS code3 codes
  • Other Individual and Family Services624190
  • Social Advocacy Organizations8133
  • Other Social Advocacy Organizations813319
SIC code3 codes
  • Services-Social Services8300
  • Services-Health Services8000
  • Services-Membership Organizations8600
Product category
Patient Advocacy and Healthcare Non-Profit Services
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Lymphoma Coalition is a worldwide not-for-profit network of more than 90 lymphoma patient organisations across 55 countries that delivers patient education, advocacy, research, and information-sharing resources for people affected by lymphoma and chronic lymphocytic leukemia (CLL). Its core deliverables include the Global Patient Survey, Global Report Cards, Health Literacy and Health Technology Assessment resources, a CAR-T Information Hub, Genetic Markers research, Psychosocial Effects resources, the Lymphoma Patient Charter, the World Lymphoma Awareness Day campaign, Special Reports, a Lymphoma Subtypes Information Library, a Resource Library of 4,000+ articles, and Clinical Trial and Treatment search tools.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Lymphoma Coalition operates as a global patient advocacy network rather than a technology company with commercial products. Its core offerings include the Global Patient Survey research program, Global Report Cards for country-level assessments, Health Literacy and HTA resources, and an extensive Lymphoma Subtypes Information Library covering B-cell and T-cell lymphomas. Additional offerings include CAR-T information hubs, Genetic Markers research, Psychosocial Effects resources, and the annual World Lymphoma Awareness Day campaign. The organization provides searchable Resource Library (4,000+ articles), Clinical Trial Search, and Treatment Database tools, alongside member organization networking (90+ organizations across 55 countries), Special Reports publications, Leadership Awards, and the Lymphoma Patient Charter advocacy document.

Product and service16 records
1Global Patient Survey on Lymphomas & CLL
CategoryResearch Program
Description

Biennial cross-sectional survey program capturing lived experiences of patients with lymphoma and CLL across multiple countries, producing data for research publications and advocacy use by member organisations, clinicians, and policy makers.

2Global Report Cards
CategoryAssessment Tool
Description

Country-level assessments measuring lymphoma and CLL outcomes, healthcare system performance, and patient access to care, used by advocates and policy stakeholders.

3Health Literacy Resources
CategoryPatient Education
Description

Educational materials and research focused on patient understanding of medical information, treatment options, and disease management.

4Health Technology Assessment (HTA) Resources
CategoryPolicy Resource
Description

Resources and information on Health Technology Assessment systems for medicines and emerging biotherapeutic products in the lymphoma treatment landscape, aimed at advocates and policy stakeholders.

5CAR-T Information Hub
CategoryPatient Education
Description

Educational resources about CAR T-cell therapy for lymphoma and CLL patients, including treatment information and research.

6Genetic Markers in Lymphoma Research
CategoryResearch Program
Description

Research initiative exploring genetic markers and molecular profiling in lymphoma diagnosis and treatment.

7Psychosocial Effects Resources
CategoryPatient Support
Description

Resources addressing fear of cancer recurrence, quality of life, fatigue, and psychological support for lymphoma patients and care partners.

8Lymphoma Patient Charter
CategoryAdvocacy Document
Description

Document outlining the rights and expectations of lymphoma patients in their care journey, used by member organisations for advocacy.

9World Lymphoma Awareness Day
CategoryAwareness Campaign
Description

Annual global awareness campaign to educate the public about lymphoma symptoms, diagnosis, and treatment.

10Karen Van Rassel Leadership Award
CategoryRecognition Program
Description

Award recognizing exceptional leadership in the lymphoma patient advocacy community.

11Special Reports
CategoryResearch Publication
Description

In-depth research publications addressing specific topics in lymphoma care, treatment access, and patient outcomes.

12Lymphoma Subtypes Information Library
CategoryPatient Education
Description

Comprehensive resources covering B-cell lymphomas (Burkitt, CLL, Cutaneous, DLBCL, Follicular, Hodgkin, Mantle Cell, Marginal Zone, Waldenström) and T-cell lymphomas (Peripheral T-Cell).

13Member Organization Network
CategorySupport Network
Description

A network of over 90 patient organisations across 55 countries providing local support and resources to lymphoma patients and a shared information hub for member organisations.

14Resource Library
CategoryInformation Repository
Description

Searchable library containing over 4,000 articles on scientific advances in research, treatments, and patient care.

15Clinical Trial Search
CategorySearch Tool
Description

Tool allowing users to find clinical trial availability by country, therapy, and lymphoma subtype.

16Treatment Database
CategorySearch Tool
Description

Searchable database of lymphoma treatments organized by therapy name, country, and lymphoma subtype.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Patient Member Organisations
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lymphoma Coalition serves as a worldwide network of patient organisations focused on lymphoma and chronic lymphocytic leukemia (CLL). Member organisations collaborate on patient education, advocacy, and support initiatives globally.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Worldwide Cancer Research is a UK-based global non-profit funding cancer research across all cancer types. Comparable to Lymphoma Coalition as a global cancer non-profit, though focused on research funding rather than patient advocacy and support.

2American Cancer Society
TypeBroad incumbent
Description

American Cancer Society is a broad incumbent US cancer advocacy non-profit covering all cancer types including lymphoma. Comparable to Lymphoma Coalition as a patient support and advocacy organization but operating at far greater scale across all cancers.

3Myeloma Patients Europe (MPE)
TypeDirect peer
Description

Myeloma Patients Europe is a European patient advocacy network for myeloma, a closely adjacent blood cancer to lymphoma. Comparable to Lymphoma Coalition in operating model (network of national patient organizations across Europe) and disease-adjacent scope.

TypeDirect peer
Description

LRF is a US-based non-profit focused exclusively on lymphoma research and patient education. It is the closest direct peer to Lymphoma Coalition in disease focus, patient support mission, and research-funding activity, though primarily serving the US market.

TypeDirect peer
Description

CLL Society is a US-based patient advocacy organization dedicated specifically to chronic lymphocytic leukemia — a core disease within Lymphoma Coalition's scope. Highly comparable as a disease-specific patient advocacy peer, though narrower in lymphoma-subtype coverage.

TypeOthers
Description

EHA is a Europe-based professional hematology organization representing clinicians and researchers in blood disorders including lymphoma. Comparable as a hematology ecosystem stakeholder that LC engages with, but operating as a professional society rather than a patient organization.

TypeEmerging player
Description

Cancer Research Institute is a US-based non-profit advancing immunotherapy research, with significant relevance to lymphoma CAR-T advocacy. Comparable to Lymphoma Coalition's emerging-therapy focus (CAR-T information hub) though primarily research rather than patient support oriented.

TypeBroad incumbent
Description

LLS is the largest US-based patient advocacy non-profit dedicated to blood cancers including lymphoma and CLL. It is comparable to Lymphoma Coalition as the most established direct-comparable peer in the same disease area with broader scope and significantly larger scale.

TypeEmerging player
Description

ECPC is a European umbrella organization representing cancer patient associations across Europe, including lymphoma. Comparable to Lymphoma Coalition as a multi-country patient advocacy network, though broader in cancer scope and overlapping in European coverage.

10International Myeloma Foundation
TypeDirect peer
Description

The International Myeloma Foundation is a global patient advocacy organization for myeloma, a related blood cancer. Comparable to Lymphoma Coalition in disease-specific patient advocacy mission, global footprint, and treatment-focused education.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lymphoma Coalition

Patient Advocacy and Healthcare Non-Profit Serviceslymphomacoalition.org

Lymphoma Coalition is a Canadian non-profit global network of over 90 patient member organizations across 55 countries, providing lymphoma and CLL patient education, advocacy, research, and policy resources since 2002.

What Lymphoma Coalition does

Lymphoma Coalition is a Canadian-incorporated non-profit and global patient advocacy network focused on lymphoma and chronic lymphocytic leukemia (CLL). Founded in 2002 by four lymphoma organizations and incorporated as a not-for-profit in 2010, it functions as a central hub connecting over 90 patient member organizations across 55 countries. Its core "products" are information assets and programs rather than commercial software: a biennial Global Patient Survey on Lymphomas & CLL, country-level Global Report Cards, a searchable Resource Library of 4,000+ articles, a Clinical Trial Search tool, a Treatment Database, a Lymphoma Subtypes Information Library covering B-cell and T-cell lymphomas, and dedicated hubs on CAR-T therapy, Genetic Markers, Biosimilars, and Psychosocial Effects. The organization also publishes policy resources including Health Technology Assessment (HTA) materials, the Lymphoma Patient Charter, the Global Health Expenditure Report 2024, and runs the annual World Lymphoma Awareness Day campaign plus the Karen Van Rassel Leadership Award.

The business model is that of a non-profit coalition rather than a commercial enterprise. LC is funded through a mix of sources typical of patient advocacy organizations (pharmaceutical unrestricted educational grants, member dues, donations, and partnerships), and revenue figures are not publicly disclosed. It has a small paid staff (1–10 employees) and is led by CEO Lorna Warwick until her December 2026 retirement; other named leaders include Natacha Bolaños (Head, Membership & Alliance) and Kathryn Perry (Head, Communications & Information). Its customer base is two-sided: member patient organizations (the primary institutional customers and channel partners) and individual patients affected by lymphoma, with secondary audiences of healthcare professionals, researchers, and policy advocates. Geographic reach is explicitly global, with active operations in Europe, Asia Pacific, North America, Latin America, and Africa, and a regional substructure for Lymphoma Coalition Europe.

Recent strategic emphasis has been on deepening clinical and policy relevance: LC supported the formation of Women in Lymphoma (WiL) in 2019, facilitated the 2021 merger of France Lymphome Espoir and SILLC into ELLyE, and announced a strategic partnership with WiL in June 2026 to combine its patient advocacy network with WiL's clinician/researcher community. As an independent non-profit with no parent company, no private equity ownership, and no public listing, governance rests with a Board of Directors, and the organization is currently conducting a global CEO search.

Lymphoma Coalition firmographics

Firmographics
Name
Lymphoma Coalition
Legal name
Lymphoma Coalition
Website
https://lymphomacoalition.org
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Lymphoma Coalition is a Canadian non-profit global network of over 90 patient member organizations across 55 countries, providing lymphoma and CLL patient education, advocacy, research, and policy resources since 2002.
Ownership category
akta.pro rank

Lymphoma Coalition industry classification

Industry
Product category
Patient Advocacy and Healthcare Non-Profit Services
NAICS
Other Individual and Family Services (624190), Social Advocacy Organizations (8133), Other Social Advocacy Organizations (813319)
SIC
Services-Social Services (8300), Services-Health Services (8000), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAO
Global Health Advocacy, Policy & Rights Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

Keywords

  • Patient advocacy network
  • Lymphoma research
  • Cancer support services
  • Healthcare education resources
  • Nonprofit patient organization

Where Lymphoma Coalition is headquartered

Location

Headquarters

HQ city
Etobicoke
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Lymphoma Coalition business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Distribution channels1 record

Marketing channels1 record

Lymphoma Coalition product offering

Product offering

Core offering

Lymphoma Coalition is a worldwide not-for-profit network of more than 90 lymphoma patient organisations across 55 countries that delivers patient education, advocacy, research, and information-sharing resources for people affected by lymphoma and chronic lymphocytic leukemia (CLL). Its core deliverables include the Global Patient Survey, Global Report Cards, Health Literacy and Health Technology Assessment resources, a CAR-T Information Hub, Genetic Markers research, Psychosocial Effects resources, the Lymphoma Patient Charter, the World Lymphoma Awareness Day campaign, Special Reports, a Lymphoma Subtypes Information Library, a Resource Library of 4,000+ articles, and Clinical Trial and Treatment search tools.

Product overview

Lymphoma Coalition operates as a global patient advocacy network rather than a technology company with commercial products. Its core offerings include the Global Patient Survey research program, Global Report Cards for country-level assessments, Health Literacy and HTA resources, and an extensive Lymphoma Subtypes Information Library covering B-cell and T-cell lymphomas. Additional offerings include CAR-T information hubs, Genetic Markers research, Psychosocial Effects resources, and the annual World Lymphoma Awareness Day campaign. The organization provides searchable Resource Library (4,000+ articles), Clinical Trial Search, and Treatment Database tools, alongside member organization networking (90+ organizations across 55 countries), Special Reports publications, Leadership Awards, and the Lymphoma Patient Charter advocacy document.

Differentiator

Problem solved

Functional benefit

Products and services

  • Global Patient Survey on Lymphomas & CLL Biennial cross-sectional survey program capturing lived experiences of patients with lymphoma and CLL across multiple countries, producing data for research publications and advocacy use by member organisations, clinicians, and policy makers.
  • Global Report Cards Country-level assessments measuring lymphoma and CLL outcomes, healthcare system performance, and patient access to care, used by advocates and policy stakeholders.
  • Health Literacy Resources Educational materials and research focused on patient understanding of medical information, treatment options, and disease management.
  • Health Technology Assessment (HTA) Resources Resources and information on Health Technology Assessment systems for medicines and emerging biotherapeutic products in the lymphoma treatment landscape, aimed at advocates and policy stakeholders.
  • CAR-T Information Hub Educational resources about CAR T-cell therapy for lymphoma and CLL patients, including treatment information and research.
  • Genetic Markers in Lymphoma Research Research initiative exploring genetic markers and molecular profiling in lymphoma diagnosis and treatment.
  • Psychosocial Effects Resources Resources addressing fear of cancer recurrence, quality of life, fatigue, and psychological support for lymphoma patients and care partners.
  • Lymphoma Patient Charter Document outlining the rights and expectations of lymphoma patients in their care journey, used by member organisations for advocacy.
  • World Lymphoma Awareness Day Annual global awareness campaign to educate the public about lymphoma symptoms, diagnosis, and treatment.
  • Karen Van Rassel Leadership Award Award recognizing exceptional leadership in the lymphoma patient advocacy community.
  • Special Reports In-depth research publications addressing specific topics in lymphoma care, treatment access, and patient outcomes.
  • Lymphoma Subtypes Information Library Comprehensive resources covering B-cell lymphomas (Burkitt, CLL, Cutaneous, DLBCL, Follicular, Hodgkin, Mantle Cell, Marginal Zone, Waldenström) and T-cell lymphomas (Peripheral T-Cell).
  • Member Organization Network A network of over 90 patient organisations across 55 countries providing local support and resources to lymphoma patients and a shared information hub for member organisations.
  • Resource Library Searchable library containing over 4,000 articles on scientific advances in research, treatments, and patient care.
  • Clinical Trial Search Tool allowing users to find clinical trial availability by country, therapy, and lymphoma subtype.
  • Treatment Database Searchable database of lymphoma treatments organized by therapy name, country, and lymphoma subtype.

Companies that use Lymphoma Coalition

Customer profile

Segments1 record

Ideal customer profiles3 records

Lymphoma Coalition technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Lymphoma Coalition partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Patient Member OrganisationscoreStrategic or Co-development PartnerLymphoma Coalition serves as a worldwide network of patient organisations focused on lymphoma and chronic lymphocytic leukemia (CLL). Member organisations collaborate on patient education, advocacy, and support initiatives globally.

Scale indicators1 record

Recent moves12 records

Expansion highlights5 records

Lymphoma Coalition competitors and assessment

Company assessment

Emerging players

  • Worldwide Cancer Research: Worldwide Cancer Research is a UK-based global non-profit funding cancer research across all cancer types. Comparable to Lymphoma Coalition as a global cancer non-profit, though focused on research funding rather than patient advocacy and support.
  • Cancer Research Institute: Cancer Research Institute is a US-based non-profit advancing immunotherapy research, with significant relevance to lymphoma CAR-T advocacy. Comparable to Lymphoma Coalition's emerging-therapy focus (CAR-T information hub) though primarily research rather than patient support oriented.
  • European Cancer Patient Coalition (ECPC): ECPC is a European umbrella organization representing cancer patient associations across Europe, including lymphoma. Comparable to Lymphoma Coalition as a multi-country patient advocacy network, though broader in cancer scope and overlapping in European coverage.

Broad incumbents

  • American Cancer Society: American Cancer Society is a broad incumbent US cancer advocacy non-profit covering all cancer types including lymphoma. Comparable to Lymphoma Coalition as a patient support and advocacy organization but operating at far greater scale across all cancers.
  • The Leukemia & Lymphoma Society (LLS): LLS is the largest US-based patient advocacy non-profit dedicated to blood cancers including lymphoma and CLL. It is comparable to Lymphoma Coalition as the most established direct-comparable peer in the same disease area with broader scope and significantly larger scale.

Direct peers

  • Myeloma Patients Europe (MPE): Myeloma Patients Europe is a European patient advocacy network for myeloma, a closely adjacent blood cancer to lymphoma. Comparable to Lymphoma Coalition in operating model (network of national patient organizations across Europe) and disease-adjacent scope.
  • Lymphoma Research Foundation (LRF): LRF is a US-based non-profit focused exclusively on lymphoma research and patient education. It is the closest direct peer to Lymphoma Coalition in disease focus, patient support mission, and research-funding activity, though primarily serving the US market.
  • CLL Society: CLL Society is a US-based patient advocacy organization dedicated specifically to chronic lymphocytic leukemia — a core disease within Lymphoma Coalition's scope. Highly comparable as a disease-specific patient advocacy peer, though narrower in lymphoma-subtype coverage.
  • International Myeloma Foundation: The International Myeloma Foundation is a global patient advocacy organization for myeloma, a related blood cancer. Comparable to Lymphoma Coalition in disease-specific patient advocacy mission, global footprint, and treatment-focused education.

Others

  • European Hematology Association (EHA): EHA is a Europe-based professional hematology organization representing clinicians and researchers in blood disorders including lymphoma. Comparable as a hematology ecosystem stakeholder that LC engages with, but operating as a professional society rather than a patient organization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Lymphoma Coalition social profiles

Digital presence

Lymphoma Coalition financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lymphoma Coalition leadership team

Management profile

Number of profiles

Profiles3 records

Lymphoma Coalition funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lymphoma Coalition M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lymphoma Coalition

What does Lymphoma Coalition do?

Lymphoma Coalition is a worldwide not-for-profit network of more than 90 lymphoma patient organisations across 55 countries that delivers patient education, advocacy, research, and information-sharing resources for people affected by lymphoma and chronic lymphocytic leukemia (CLL). Its core deliverables include the Global Patient Survey, Global Report Cards, Health Literacy and Health Technology Assessment resources, a CAR-T Information Hub, Genetic Markers research, Psychosocial Effects resources, the Lymphoma Patient Charter, the World Lymphoma Awareness Day campaign, Special Reports, a Lymphoma Subtypes Information Library, a Resource Library of 4,000+ articles, and Clinical Trial and Treatment search tools.

Is Lymphoma Coalition a public or private company?

Lymphoma Coalition is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Lymphoma Coalition founded?

Lymphoma Coalition was founded in 2002. It employs 11 to 50 people.

Where is Lymphoma Coalition based?

Lymphoma Coalition is headquartered in Etobicoke, Canada, in the North America region.

Who are Lymphoma Coalition's main competitors?

Emerging players on record are Worldwide Cancer Research, Cancer Research Institute and European Cancer Patient Coalition (ECPC). Broad incumbents are American Cancer Society and The Leukemia & Lymphoma Society (LLS). Direct peers are Myeloma Patients Europe (MPE), Lymphoma Research Foundation (LRF), CLL Society and International Myeloma Foundation. European Hematology Association (EHA) is listed as an others.

Does Lymphoma Coalition have an API?

No public API is recorded for Lymphoma Coalition.

What industry is Lymphoma Coalition in?

Lymphoma Coalition's product category is Patient Advocacy and Healthcare Non-Profit Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of HLAJAKAO, Global Health Advocacy, Policy & Rights Organizations. Its NAICS code is 624190 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales